Zobrazeno 1 - 10
of 313
pro vyhledávání: '"Eva Comperat"'
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-5 (2024)
Abstract Background Fasciitis ossificans is a rare subtype of nodular fasciitis, a benign soft tissue tumor with reactive characteristics. Due to its rapid growth, it is often misdiagnosed as a malignant tumor. While fasciitis ossificans commonly ori
Externí odkaz:
https://doaj.org/article/98655aeab45a41ce9d2bc67554b52edd
Autor:
Meenakshi Anurag, Trine Strandgaard, Sung Han Kim, Yongchao Dou, Eva Comperat, Hikmat Al-Ahmadie, Brant A. Inman, Ann Taber, Iver Nordentoft, Jørgen Bjerggaard Jensen, Lars Dyrskjøt, Seth P. Lerner
Publikováno v:
iScience, Vol 27, Iss 3, Pp 109179- (2024)
Summary: Urothelial carcinoma in situ (CIS) is an aggressive phenotype of non-muscle-invasive bladder cancer. Molecular features unique to CIS compared to high-grade papillary tumors are underexplored. RNA sequencing of CIS, papillary tumors, and nor
Externí odkaz:
https://doaj.org/article/421e0ea543b3460ab11bc4bd706a726b
Autor:
Florian A. Büttner, Stefan Winter, Viktoria Stühler, Steffen Rausch, Jörg Hennenlotter, Susanne Füssel, Stefan Zastrow, Matthias Meinhardt, Marieta Toma, Carmen Jerónimo, Rui Henrique, Vera Miranda-Gonçalves, Nils Kröger, Silvia Ribback, Arndt Hartmann, Abbas Agaimy, Christine Stöhr, Iris Polifka, Falko Fend, Marcus Scharpf, Eva Comperat, Gabriel Wasinger, Holger Moch, Arnulf Stenzl, Marco Gerlinger, Jens Bedke, Matthias Schwab, Elke Schaeffeler
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-19 (2022)
Abstract Background Renal cell carcinoma (RCC) is a heterogeneous disease comprising histologically defined subtypes. For therapy selection, precise subtype identification and individualized prognosis are mandatory, but currently limited. Our aim was
Externí odkaz:
https://doaj.org/article/876bc134c9284335b9606279982c1274
Autor:
Bettina Trimmel, Andre Oszwald, Christoph Diemand, Iris E. Ertl, Ursula Lemberger, Andreas Bruchbacher, Robert Brettner, Stephan Korn, Irene Resch, Eva Comperat, Shahrokh F. Shariat, Melanie R. Hassler
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Squamous cell carcinoma of the penis (PSC) is a rare disease with limited information on the molecular events leading to malignant transformation. In a third of PSC cases, presence of human papilloma virus (HPV) is found. The APOBEC3 family
Externí odkaz:
https://doaj.org/article/3aa2b5c569dc4bdc90c7d05d36bb9d7e
Autor:
Judith Stangl-Kremser, Sazan Rasul, Jeffrey J. Tosoian, Simpa S. Salami, Alexander Zaslavsky, Aaron Udager, Peter Mazal, Renate Kain, Eva Comperat, Marcus Hacker, Alexander Haug, Markus Mitterhauser, Carmen Pozo-Salido, Christina Steinbach, Melanie R. Hassler, Gero Kramer, Shahrokh F. Shariat, Ganesh S. Palapattu
Publikováno v:
European Urology Open Science, Vol 30, Iss , Pp 63-66 (2021)
Initial reports of a clinical response in patients treated with the radioligand [177Lu]-PSMA-617 for castration-resistant prostate cancer (CRPC) are promising, despite known inter- and intrapatient heterogeneity. In metastatic CRPC, we examined the a
Externí odkaz:
https://doaj.org/article/a2b9edb485a247728f43555379aaa0bd
Autor:
Michele Lamuraglia MD, PhD, Guillaume Barrois PhD, Delphine Le Guillou-Buffello PhD, Mathieu Santin PhD, Anne Kerbol MD, Eva Comperat MD, Alain Coron PhD, Olivier Lucidarme MD, PhD, S. Lori Bridal PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Background: Association of drugs acting against different antiangiogenic mechanisms may increase therapeutic effect and reduce resistance. Noninvasive monitoring of changes in the antiangiogenic response of individual tumors could guide selection and
Externí odkaz:
https://doaj.org/article/2610f329007a496f912eed53288c2f3f
Autor:
Alexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, Joseph Gligorov, Jean-Pierre Lotz, Didier Brault, Eva Comperat, Guillaume Lefèvre, Mathieu Boissan
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227356 (2020)
BACKGROUND:The transmembrane receptor tyrosine kinase HER2 is overexpressed in approximately 15% of breast tumors and correlates with poor clinical prognosis. Several treatments that target HER2 are approved for treatment of HER2-positive metastatic
Externí odkaz:
https://doaj.org/article/bf3795ccb7434f9bb8c0c7cd94d5f75a
Autor:
Mario Pones, David D’Andrea, Keiichiro Mori, Mohammad Abufraj, Marco Moschini, Eva Comperat, Shahrokh F. Shariat
Publikováno v:
Cancers, Vol 13, Iss 10, p 2496 (2021)
To evaluate oncological outcomes of primary versus secondary muscle-invasive bladder cancer treated with radical cystectomy. Medline, Embase, Scopus and Cochrane Library were searched for eligible studies. Hazard ratios for overall survival (OS), can
Externí odkaz:
https://doaj.org/article/50b75deeb1e345b7873ae7b5af3ff073
Autor:
Renate Pichler, Andrea Katharina Lindner, Georg Schäfer, Gennadi Tulchiner, Nina Staudacher, Martin Mayr, Eva Comperat, Jacob J. Orme, Gert Schachtner, Martin Thurnher
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 4, p 764 (2021)
Although Bacillus Calmette Guérin (BCG) remains a mainstay of adjuvant treatment in high-risk, non-muscle-invasive bladder cancer, BCG failure occurs in up to 40% of patients, with radical cystectomy (RC) as the inevitable therapeutic consequence. C
Externí odkaz:
https://doaj.org/article/5e5610aaa96d4793bc330957653b80eb
Publikováno v:
Case Reports in Medicine, Vol 2009 (2009)
A 57-year-old woman was found to have an inferior vena cava involvement of a known sinusal angiomyolipoma incompletely resected three years beforehand. Intravascular extension into the IVC of angiomyolipoma has rarely been reported. We present a new
Externí odkaz:
https://doaj.org/article/13a1a63b61d44566b3e156c7a839a002